Speaking Engagement Recap
June 30, 2021
Towards a Patient-Focused Drug Development Ecosystem: Adoption of Core Outcome Sets
DIA 2021 Global Annual Meeting
Faegre Drinker Consulting Director Allison Martin joined a panel of agency officials and industry professionals to discuss the ecosystem of patient-focused drug development and patient-focused outcome measures. The panel explored efforts by regulators and the patient community to develop core outcome sets and discussed how these can be leveraged to support drug development programs and facilitate shared learnings. Allison’s presentation, from the perspective of UsAgainstAlzheimer’s AD PACE (Alzheimer’s Disease Patient and Caregiver Engagement) initiative, explored the need for clinical trial outcome assessments that measure what matters most to Alzheimer’s patients and caregivers.